Today's World Situation is Related to The COVID-19

Coronavirus disease 2019 (COVID-19)
Today's World Situation is Related to The COVID-19 total (new) cases in the last 24 hours:

• Globally 750 890 Confirmed 57 610 (36 405) Deaths 3301
• Western Pacific Region 104 868 confirmed (1093) 3671 deaths 22
• European Region 423 946 confirmed (31 131) 26 694 deaths 2733
• South-East Asia Region 4215 confirmed (131) 166 deaths 8
• Eastern Mediterranean Region 50 349 confirmed (4020) 2954 deaths 142
• Region of the Americas 163 014 confirmed (20 935) 2836 deaths 379
• African Region 3786 confirmed (300) 77 deaths 17
• WHO Risk Assessment - Global Level (Very High)

Highlights

1. No new countries/territories/areas reported cases of COVID-19 in the past 24 hours.
2. As mentioned by the Director-General in his regular media briefing yesterday, ensuring free movement of essential health products is vital for saving lives and curbing the social and economic impacts of the pandemic. WHO is working intensively with partners to increase access to life-saving products, including diagnostics, PPE, medical oxygen, ventilators and more.
3. Operations support and logistics continue to monitor critical markets and in partnership with the Pandemic Supply Chain Network, has increased engagement and coordination with private companies. Since the beginning of the outbreak, OSL has shipped more than 800 000 surgical masks, 54 000 N95 masks, 873 000 globes, 15 000 goggles and 24 000 face shields to 75 countries. OSL has also shipped COVID-19 testing kits to 126 countries. For more details, please see ‘subject in focus’.As mentioned by the Director-General in his regular media briefing yesterday, ensuring free movement of essential health products is vital for saving lives and curbing the social and economic impacts of the pandemic. WHO is working intensively with partners to increase access to life-saving products, including diagnostics, PPE, medical oxygen, ventilators and more. 

Subject in Focus

WHO Strengthens supply chains and releases guidance on setting up treatment centres. WHO Operations Support and Logistics (OSL) continues to support the COVID-19 emergency operations despite continued disruption to critical supply markets where demand outpaces global supply.

Since the beginning of the outbreak, OSL has shipped more than 800 000 surgical masks, 54 000 N95 masks, 873 000 globes, 15 000 goggles and 24 000 face shields to 75 countries. OSL has also shipped COVID-19 testing kits to 126 countries.

A Supply Chain Inter-Agency Coordination Cell has been established to provide an overview of supply chain requirements and ensure that COVID-19 needs are prioritized within the wider humanitarian response. The Supply Chain Inter-Agency Coordination Cell has established a Supply and Market Working Group to streamline procurement of critical supplies and equipment to address global shortages.

A common platform for private-sector donations of critical items in support of the COVID-19 response will be announced shortly. The list of critical items is available online.

OSL continues to monitor critical markets and has increased engagement and coordination with private companies, in partnership with the Pandemic Supply Chain Network.

OSL has released the first edition of a practical manual to set up and manage a Severe Acute Respiratory Infection (SARI) treatment centre and a SARI screening facility in health-care facilities. The manual is available online, and accompanying training modules are available to the public through Open WHO.

• Module 1: Overview of basic operational and IPC principles in COVID-19 context;
• Module 2: Designing a SARI screening area and treatment centre;
• Module 3: Repurposing an existing building into a SARI treatment centre.

An additional module for WASH (water, sanitation and hygiene), waste management, energy requirements and installations for SARI facilities is currently under development.

OSL is also working to build tactical infection prevention and control (IPC) surge support to hospitals with an aim to help improve infectious disease management protocols, limit nosocomial transmission and support rational consumption of personal protective equipment.

SURVEILLANCE

The table below countries, territories or areas with reported laboratory-confirmed COVID-19 cases and deaths. Data as of 31 March 2020*

Detail Table Below Link :

Report Table Coronavirus Update here link

Due to differences in reporting methods, retrospective data consolidation, and reporting delays, the number of new cases may not always reflect the exact difference between yesterday’s and today’s totals. WHO COVID-19 Situation Reports present official counts of confirmed COVID-19 cases, thus differences between WHO reports and other sources of COVID-19 data using different inclusion criteria and different data cutoff times are to be expected.

Strategic Objectives

WHO’s strategic objectives for this response are to:

• Interrupt human-to-human transmission including reducing secondary infections among close contacts and health care workers, preventing transmission amplification events, and preventing further international spread*;
• Identify, isolate and care for patients early, including providing optimized care for infected patients;
• Identify and reduce transmission from the animal source;
• Address crucial unknowns regarding clinical severity, the extent of transmission and infection, treatment options, and accelerate the development of diagnostics, therapeutics and vaccines;
• Communicate critical risk and event information to all communities and counter misinformation;
• Minimize social and economic impact through multisectoral partnerships.

*This can be achieved through a combination of public health measures, such as rapid identification, diagnosis and management of the cases, identification and follow up of the contacts, infection prevention and control in health care settings, implementation of health measures for travellers, awareness-raising in the population and risk communication.

PREPAREDNESS AND RESPONSE

WHO has developed interim guidance for laboratory diagnosis, advice on the use of masks during home care and in health care settings in the context of the novel coronavirus (2019-nCoV) outbreak, clinical management, infection prevention and control in health care settings, home care for patients with suspected novel coronavirus, risk communication and community engagement and Global Surveillance for human infection with the novel coronavirus (2019-nCoV).

WHO is working closely with the International Air Transport Association (IATA) and have jointly developed a guidance document to provide advice to cabin crew and airport workers, based on country queries. WHO has been in regular and direct contact with the Member States where cases have been reported. WHO is also informing other countries about the situation and providing support as requested.

WHO is working with its networks of researchers and other experts to coordinate global work on surveillance, epidemiology, mathematical modelling, diagnostics and virology, clinical care and treatment, infection prevention and control, and risk communication. WHO has issued interim guidance for countries, which are updated regularly.

RECOMMENDATIONS AND ADVICE FOR THE PUBLIC

If you are not in an area where COVID-19 is spreading or have not travelled from an area where COVID-19 is spreading or have not been in contact with an infected patient, your risk of infection is low. It is understandable that you may feel anxious about the outbreak. Get the facts from reliable sources to help you accurately determine your risks so that you can take reasonable precautions. Seek guidance from WHO, your healthcare provider, your national public health authority or your employer for accurate information on COVID-19 and whether COVID-19 is circulating where you live. It is important to be informed of the situation and take appropriate measures to protect yourself and your family.

If you are in an area where there are cases of COVID-19 you need to take the risk of infection seriously. Follow the advice of WHO and guidance issued by national and local health authorities. For most people, COVID-19 infection will cause mild illness however, it can make some people very ill and, in some people, it can be fatal. Older people and those with pre-existing medical conditions (such as cardiovascular disease, chronic respiratory disease or diabetes) are at risk for severe disease (See Protection measures for persons who are in or have recently visited (past 14 days) areas where COVID-19 is spreading).

CASE DEFINITIONS

WHO periodically updates the Global Surveillance for human infection with coronavirus disease (COVID-19) document which includes case definitions.

Note: for confirmed asymptomatic cases, the period of contact is measured as the 2 days before through the 14 days after the date on which the sample was taken which led to confirmation.